ASAM responded to an RFI regarding challenges, failures, fraud and abuse within the SUD treatment industry, as well as opportunities to improve the quality of treatment.

ASAM submitted its comments on SAMHSA's NPRM Regarding Confidentiality of Substance Use Disorder Patient Records, which would make significant regulatory changes to 42 CFR Part 2

Updated definition of addiction to explain more fully the complexity of this chronic disease with the intent of driving a bold and comprehensive national response.

ASAM mourns the loss of the longtime Maryland Congressman who was a tireless advocate for the people he served and a true champion for expanding access to addiction treatment and recovery in the US.

ASAM applauds a provision of the Reversing the Youth Tobacco Epidemic Act that would ban menthol cigarettes, observing that menthol cigarettes are uniquely attractive to youth.

The Journal of Law, Medicine & Ethics has accepted a letter to the editor urging the Accreditation Council for Graduate Medical Education (ACGME) establish a requirement that all residents and fellows who care for patients who use opioids, as well as their core faculty, receive specific training on the treatment of opioid use disorder (OUD).

ASAM submitted its comments on the 2020 Medicare Physician Fee Schedule proposed rule, which focus on the two newly proposed payment bundles for the treatment of opioid use disorder, and a provision of the proposed rule that would permit CMS to revoke or deny Medicare enrollment for physicians and eligible professionals under certain circumstances.

ASAM submitted comments on a Notice of Proposed Rulemaking (NPRM) regarding Confidentiality of Substance Use Disorder Patient Records which would expand the ability of law enforcement to access records protected by 42 CFR Part 2.